+ Thank you to those who attended the luncheon!
Have a look at our article to find out what was discussed!
We are pleased to invite you to our November Luncheon with Dr. Simone Wyss Fedele, CEO of Switzerland Global Enterprise (S-GE), who will deliver a speech titled “Switzerland and Japan, Two Islands with Similar Strength and Opportunities”.
Like Switzerland, Japan offers international companies a politically and legally stable environment and is open to innovation. Thus, Japan is an interesting market, offering opportunities where Swiss companies are strong and can contribute with high-tech solutions. Moreover, Japanese companies are also important for Switzerland as a business location. However, current geopolitical developments are shaping international business. The structural reorganization of value chains is currently the subject of debate. Companies are faced with new challenges, but also new opportunities. In her presentation for the SCCIJ, Dr. Simone Wyss Fedele, CEO of Switzerland Global Enterprise (S-GE), will explain how these developments affect Swiss companies and their business in the Japanese market.
Date & Time: |
Tuesday, November 15, 2022 |
---|---|
Venue: |
Grand Hyatt Tokyo (MAP) |
Entry Fee: |
|
Registration: |
*Fully booked* |
Safety measures: |
|
Inquiries: |
By e-mail to info@sccij.jp |
Biography of the Speaker:
Dr. Simone Wyss Fedele is the CEO of Switzerland Global Enterprise, the official Swiss organization for export and investment promotion with offices throughout Switzerland and in 31 countries. After completing her doctorate in international economics, she worked for around 20 years in the life science, MEM and insurance industries. She worked in the companies’ core business and at the interface with business associations, authorities and the government. For example, she worked in marketing at Endress+Hauser, was responsible for product launches in over 30 countries at Takeda Pharmaceuticals, and was in charge of public affairs at Helvetia. Most recently, Simone Wyss Fedele was the Chief Economist at Novartis and was part of the Executive Committee of Novartis Switzerland as the Head of Public Affairs. Since 2021, she has also served on the Supervisory Board of the biotech company Infors AG and on the Executive Committee of the Swiss Institute for International Economics and Applied Economic Research (SIAF) at the University of St. Gallen.